Report Categories
View AllRecent Articles
View All
FBRT Franklin posts 577 percent Q4 2025 EPS miss trades slightly higher despite weaker than expected results
AKAM Akamai rises 458 percent after delivering a modest Q4 2025 earnings per share beat over analyst forecasts
X4 Pharmaceuticals XFOR Stock Directional Bias Review Q4 2025 Earnings Beat Estimates
KLRS Kalaris Therapeutics Q4 loss narrows more than expected lifting shares 178 on positive sentiment